Sept 12 (Reuters) - AFT Pharmaceuticals Ltd (AFT) :
- Company is estimating it will sell approximately 72 million tablets worldwide
in FY 2017
- Provides FY 2017 sales forecast for patented product, maxigesic
- Patented nasosurf nebuliser "on track to file first regulatory filing with US
food and drug administration this calendar year"
- Source text (http://bit.ly/2ckazLq)
- (( )) (([email protected]))
News: AFP AFT Pharmaceuticals provides FY17 sales forecast for patented product Maxigesic
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.56 |
Change
-0.030(1.16%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.61 | $2.50 | $10.59K | 4.143K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400 | $2.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.98 | 1250 | 1 |
View Market Depth
| Last trade - 12.30pm 29/07/2025 (20 minute delay) ? |
| AFP (ASX) Chart |